SCHEMBL7879418

SCHEMBL7879418

CNC(N)=NC(=O)c1cc2c(Cl)cc(Oc3ccccc3[N+](=O)[O-])cc2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.39
RHEB Q15382 3/20 0.39
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
POLB P06746 1/20 0.35
HTR6 P50406 1/20 0.35
CHEK2 O96017 1/20 0.35
GAA P10253 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
XDH P47989 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
SLC9A1 P19634 1/20 0.34
HSP90AA1 P07900 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7881935 0.88 RHEB (0.37) RHEBMAPTLMNAL3MBTL1POLB
SCHEMBL7880009 0.86 RHEB (0.42) RHEBGAAMEN1KMT2AALDH1A1
SCHEMBL7885053 0.85 HTR6 (0.40) HPGDMAPTL3MBTL1POLBHTR6
Hydrochloric Acid SCHEMBL7879995 0.85 RHEB (0.41) RHEBGAAMEN1KMT2AALDH1A1
SCHEMBL7879700 0.84 LGALS8 (0.42) RHEBMAPTLMNACHEK2GAA
SCHEMBL7884783 0.84 KMT2A (0.40) RHEBMAPTLMNAGAAMEN1
SCHEMBL7879891 0.83 RHEB (0.50) RHEBCHEK2KMT2AXDH
SCHEMBL7880770 0.83 CYP3A4 (0.40) RHEBMEN1KMT2ACYP2C19NPC1
SCHEMBL7884883 0.83 ATM (0.33) RHEBMAPTPOLBMEN1KMT2A
SCHEMBL7879818 0.83 LMNA (0.46) HPGDMAPTLMNAL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed